These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35459560)

  • 21. ADARs, RNA editing and more in hematological malignancies.
    Teoh PJ; Koh MY; Chng WJ
    Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
    Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
    Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural impacts of two disease-linked ADAR1 mutants: a molecular dynamics study.
    Huang WC; Hsu CH; Albu TV; Yang CN
    J Comput Aided Mol Des; 2024 Jul; 38(1):25. PubMed ID: 39014124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
    Ramírez-Moya J; Miliotis C; Baker AR; Gregory RI; Slack FJ; Santisteban P
    Mol Cancer; 2021 Sep; 20(1):115. PubMed ID: 34496885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.
    Thuy-Boun AS; Thomas JM; Grajo HL; Palumbo CM; Park S; Nguyen LT; Fisher AJ; Beal PA
    Nucleic Acids Res; 2020 Aug; 48(14):7958-7972. PubMed ID: 32597966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
    George CX; Gan Z; Liu Y; Samuel CE
    J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonistic and stimulative roles of ADAR1 in RNA silencing.
    Nishikura K; Sakurai M; Ariyoshi K; Ota H
    RNA Biol; 2013 Aug; 10(8):1240-7. PubMed ID: 23949595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revealing Differential RNA Editing Specificity of Human ADAR1 and ADAR2 in
    Zhang N; Chen P; Cui Z; Zhou X; Hao C; Xie B; Hao P; Ye BC; Li X; Jing X
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
    Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
    Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the principles of the RNA editing code via large-scale systematic probing.
    Uzonyi A; Nir R; Shliefer O; Stern-Ginossar N; Antebi Y; Stelzer Y; Levanon EY; Schwartz S
    Mol Cell; 2021 Jun; 81(11):2374-2387.e3. PubMed ID: 33905683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.
    Samuel CE
    J Biol Chem; 2019 Feb; 294(5):1710-1720. PubMed ID: 30710018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of ADAR1 through and beyond its editing activity in cancer.
    Jiao Y; Xu Y; Liu C; Miao R; Liu C; Wang Y; Liu J
    Cell Commun Signal; 2024 Jan; 22(1):42. PubMed ID: 38233935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
    Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
    J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
    Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
    J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.